Literature DB >> 19540583

Memory antibody response from antigen loaded polymer particles and the effect of antigen release kinetics.

Vibhu Kanchan1, Yogesh K Katare, Amulya K Panda.   

Abstract

Memory antibody response is the hallmark of long lasting immunity. In this study, we report the generation of memory antibody response while immunizing with single dose of polymer particle entrapped antigens. Immunization with admixture of alum and polylactide (PLA) polymer particles (2-8 microm) entrapping antigens not only elicited long lasting primary antibody response but also very high levels of memory antibody titer upon re-exposure to very small amount of soluble antigen. In the case of tetanus toxoid (TT), the memory antibody titers from PLA particle based immunization were almost four times higher than that achieved from two doses of alum adsorbed antigen and sustained at a higher level for a longer period of time. Memory antibody response was detected even after challenging the animals after 18 months of primary immunization. Similar enhanced memory antibody response was also observed in the case of immunization with PLA particle entrapping diphtheria toxoid (DT). Memory antibody response generated from polymeric formulations was highly antigen specific. Polymer particles with different release profile of antigen were used as a model system to evaluate the role of antigen on immunological memory. The results suggest that slow and continuous release of antigen from polymer particles plays a critical role in eliciting improved memory antibody response from single point immunization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540583     DOI: 10.1016/j.biomaterials.2009.05.075

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  11 in total

1.  Polymer blend particles with defined compositions for targeting antigen to both class I and II antigen presentation pathways.

Authors:  Kenny K Tran; Xi Zhan; Hong Shen
Journal:  Adv Healthc Mater       Date:  2013-10-02       Impact factor: 9.933

Review 2.  Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines.

Authors:  Stacey L Demento; Alyssa L Siefert; Arunima Bandyopadhyay; Fiona A Sharp; Tarek M Fahmy
Journal:  Trends Biotechnol       Date:  2011-04-02       Impact factor: 19.536

3.  RBD decorated PLA nanoparticle admixture with aluminum hydroxide elicit robust and long lasting immune response against SARS-CoV-2.

Authors:  Jairam Meena; Priyank Singhvi; Sudeepa Srichandan; Jyotsna Dandotiya; Juhi Verma; Mamta Singh; Rahul Ahuja; Neha Panwar; Tabiya Qayoom Wani; Ritika Khatri; Gazala Siddiqui; Anuradha Gupta; Sweety Samal; Amulya Kumar Panda
Journal:  Eur J Pharm Biopharm       Date:  2022-05-17       Impact factor: 5.589

4.  Retention of structure, antigenicity, and biological function of pneumococcal surface protein A (PspA) released from polyanhydride nanoparticles.

Authors:  Shannon L Haughney; Latrisha K Petersen; Amy D Schoofs; Amanda E Ramer-Tait; Janice D King; David E Briles; Michael J Wannemuehler; Balaji Narasimhan
Journal:  Acta Biomater       Date:  2013-06-14       Impact factor: 8.947

5.  Nanoparticles of Chitosan/Poly(D,L-Lactide-Co-Glycolide) Enhanced the Immune Responses of Haemonchus contortus HCA59 Antigen in Model Mice.

Authors:  Qiangqiang Wang; Xiaoke Sun; Xin Huang; Jianmei Huang; Muhammad Waqqas Hasan; RuoFeng Yan; Lixin Xu; Xiaokai Song; Xiangrui Li
Journal:  Int J Nanomedicine       Date:  2021-05-04

Review 6.  PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity.

Authors:  A L Silva; P C Soema; B Slütter; F Ossendorp; W Jiskoot
Journal:  Hum Vaccin Immunother       Date:  2016-01-11       Impact factor: 3.452

Review 7.  Engineering nanoparticles to overcome barriers to immunotherapy.

Authors:  Randall Toy; Krishnendu Roy
Journal:  Bioeng Transl Med       Date:  2016-06-20

Review 8.  Toxicology of Engineered Nanoparticles: Focus on Poly(amidoamine) Dendrimers.

Authors:  Pratap C Naha; Sourav P Mukherjee; Hugh J Byrne
Journal:  Int J Environ Res Public Health       Date:  2018-02-14       Impact factor: 3.390

Review 9.  Hitchhiking on Controlled-Release Drug Delivery Systems: Opportunities and Challenges for Cancer Vaccines.

Authors:  Lu Han; Ke Peng; Li-Ying Qiu; Meng Li; Jing-Hua Ruan; Li-Li He; Zhi-Xiang Yuan
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

Review 10.  Advancements in prophylactic and therapeutic nanovaccines.

Authors:  Prateek Bhardwaj; Eshant Bhatia; Shivam Sharma; Nadim Ahamad; Rinti Banerjee
Journal:  Acta Biomater       Date:  2020-04-05       Impact factor: 10.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.